Research and Development

Somerset, NJ – March 7, 2012 — Catalent Pharma Solutions announced the completion of extended warehousing facilities in Schorndorf, Germany …

Somerset, NJ February 21, 2012 — Michael Jenkins, Ph.D., General Manager of Catalent Pharma Solutions’ Middleton, WI facility, will present …

Dr John Brown has been appointed as a non-executive director to the board of BioCity Nottingham Ltd, which runs one …

GlaxoSmithKline has expanded its apprenticeship programme with the creation of positions spanning manufacturing, IT, and R&D.  The multi-disciplinary scheme is …

Janssen’s prostate cancer pill Zytiga could be on course to target a larger number of patients following a positive late-stage …

UCB has confirmed that its chief executive Roch Doliveux has been appointed chairman of the governing board of the Innovative …

 Renal cell carcinoma Pfizer’s Inlyta (axitinib) has been approved as second line treatment for renal cell carcinoma. The drug is …

Patients with severe forms of Alzheimer’s disease should stay on Pfizer’s Aricept for longer, according to new research. A new …

The National Institute for Health and Clinical Excellence (NICE) has appointed two new directors. Professor Mark Baker will be the …

Ranbaxy has launched its generic version of Pfizer’s Lipitor in Europe, months ahead of its May expiration date.  The Indian …

In many markets the corporate brand can add significant value and values to the portfolio of product brands and franchises. …

The ABPI has appointed Catherine Meaden as its new head of policy and public affairs. She will join the UK …

GlaxoSmithKline has teamed up with Dundee University and the Wellcome Trust to develop new drugs for neglected diseases.  Healthcare charity …

Mundipharma International has appointed Paul Medeiros as its new head of corporate and business development at its Cambridge, UK site.  …

CPR opens first bioanalytical lab in Singapore, PRA wins an MS vaccine trial contract, plus M&A and alliance news from …